Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study. / Juhl, Pernille; Iversen, Line Vinderslev; Karlsmark, Tonny; Karsdal, Morten Asser; Bay-Jensen, Anne-Christine; Mogensen, Mette; Siebuhr, Anne Sofie.

I: Biomarkers, Bind 24, Nr. 4, 2019, s. 373-378.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Juhl, P, Iversen, LV, Karlsmark, T, Karsdal, MA, Bay-Jensen, A-C, Mogensen, M & Siebuhr, AS 2019, 'Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study', Biomarkers, bind 24, nr. 4, s. 373-378. https://doi.org/10.1080/1354750X.2019.1587509

APA

Juhl, P., Iversen, L. V., Karlsmark, T., Karsdal, M. A., Bay-Jensen, A-C., Mogensen, M., & Siebuhr, A. S. (2019). Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study. Biomarkers, 24(4), 373-378. https://doi.org/10.1080/1354750X.2019.1587509

Vancouver

Juhl P, Iversen LV, Karlsmark T, Karsdal MA, Bay-Jensen A-C, Mogensen M o.a. Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study. Biomarkers. 2019;24(4):373-378. https://doi.org/10.1080/1354750X.2019.1587509

Author

Juhl, Pernille ; Iversen, Line Vinderslev ; Karlsmark, Tonny ; Karsdal, Morten Asser ; Bay-Jensen, Anne-Christine ; Mogensen, Mette ; Siebuhr, Anne Sofie. / Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study. I: Biomarkers. 2019 ; Bind 24, Nr. 4. s. 373-378.

Bibtex

@article{0762a4599ce3484f8c6a81b3546406b8,
title = "Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study",
abstract = "Objective: The objective was to investigate blood-based biomarkers of type I (PRO-C1), III (PRO-C3) and VI (PRO-C6) collagen formation in systemic sclerosis (SSc) patients and examine their correlation to modified Rodnan skin score (mRSS). Methods: Limited (lSSc, n = 76) and diffuse SSc (dSSc, n = 41) fulfilling the ACR/EULAR 1980 and 2013 classification criteria for SSc and asymptomatic controls (n = 9) were included. PRO-C1, PRO-C3 and PRO-C6 were measured in serum. Results: LSSc compared to dSSc were significantly older, had longer disease duration and lower mRSS. PRO-C3 was higher in early dSSc compared to early lSSc (mean [95 percentile], 27.4 [13.1-39.1] ng/mL vs 14.9 [8.2-28.8] ng/mL, p = 0.006). PRO-C6 levels were higher in early dSSc compared to early lSSc and late dSSc (early dSSc: 28.2 [10.4-92.3] ng/ml vs early lSSc: 11.0 [6.9-28.5] ng/ml; p = 0.006 and late dSSc: 12.6 [6.5-25.3] ng/mL, p = 0.04). No difference was observed with PRO-C1. PRO-C3 and PRO-C6 were moderately correlated with mRSS with R-partials of 0.36 (p < 0.001) and 0.29 (p = 0.002), respectively Conclusion: Measures of type III and VI collagen formation are potential objective biomarkers of fibrosis in systemic sclerosis. These biomarkers could be useful in monitoring the disease and efficacy of treatment.",
keywords = "Systemic sclerosis, collagen, metabolites, modified Rodnan skin score, scleroderma",
author = "Pernille Juhl and Iversen, {Line Vinderslev} and Tonny Karlsmark and Karsdal, {Morten Asser} and Anne-Christine Bay-Jensen and Mette Mogensen and Siebuhr, {Anne Sofie}",
year = "2019",
doi = "10.1080/1354750X.2019.1587509",
language = "English",
volume = "24",
pages = "373--378",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Taylor & Francis",
number = "4",

}

RIS

TY - JOUR

T1 - Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study

AU - Juhl, Pernille

AU - Iversen, Line Vinderslev

AU - Karlsmark, Tonny

AU - Karsdal, Morten Asser

AU - Bay-Jensen, Anne-Christine

AU - Mogensen, Mette

AU - Siebuhr, Anne Sofie

PY - 2019

Y1 - 2019

N2 - Objective: The objective was to investigate blood-based biomarkers of type I (PRO-C1), III (PRO-C3) and VI (PRO-C6) collagen formation in systemic sclerosis (SSc) patients and examine their correlation to modified Rodnan skin score (mRSS). Methods: Limited (lSSc, n = 76) and diffuse SSc (dSSc, n = 41) fulfilling the ACR/EULAR 1980 and 2013 classification criteria for SSc and asymptomatic controls (n = 9) were included. PRO-C1, PRO-C3 and PRO-C6 were measured in serum. Results: LSSc compared to dSSc were significantly older, had longer disease duration and lower mRSS. PRO-C3 was higher in early dSSc compared to early lSSc (mean [95 percentile], 27.4 [13.1-39.1] ng/mL vs 14.9 [8.2-28.8] ng/mL, p = 0.006). PRO-C6 levels were higher in early dSSc compared to early lSSc and late dSSc (early dSSc: 28.2 [10.4-92.3] ng/ml vs early lSSc: 11.0 [6.9-28.5] ng/ml; p = 0.006 and late dSSc: 12.6 [6.5-25.3] ng/mL, p = 0.04). No difference was observed with PRO-C1. PRO-C3 and PRO-C6 were moderately correlated with mRSS with R-partials of 0.36 (p < 0.001) and 0.29 (p = 0.002), respectively Conclusion: Measures of type III and VI collagen formation are potential objective biomarkers of fibrosis in systemic sclerosis. These biomarkers could be useful in monitoring the disease and efficacy of treatment.

AB - Objective: The objective was to investigate blood-based biomarkers of type I (PRO-C1), III (PRO-C3) and VI (PRO-C6) collagen formation in systemic sclerosis (SSc) patients and examine their correlation to modified Rodnan skin score (mRSS). Methods: Limited (lSSc, n = 76) and diffuse SSc (dSSc, n = 41) fulfilling the ACR/EULAR 1980 and 2013 classification criteria for SSc and asymptomatic controls (n = 9) were included. PRO-C1, PRO-C3 and PRO-C6 were measured in serum. Results: LSSc compared to dSSc were significantly older, had longer disease duration and lower mRSS. PRO-C3 was higher in early dSSc compared to early lSSc (mean [95 percentile], 27.4 [13.1-39.1] ng/mL vs 14.9 [8.2-28.8] ng/mL, p = 0.006). PRO-C6 levels were higher in early dSSc compared to early lSSc and late dSSc (early dSSc: 28.2 [10.4-92.3] ng/ml vs early lSSc: 11.0 [6.9-28.5] ng/ml; p = 0.006 and late dSSc: 12.6 [6.5-25.3] ng/mL, p = 0.04). No difference was observed with PRO-C1. PRO-C3 and PRO-C6 were moderately correlated with mRSS with R-partials of 0.36 (p < 0.001) and 0.29 (p = 0.002), respectively Conclusion: Measures of type III and VI collagen formation are potential objective biomarkers of fibrosis in systemic sclerosis. These biomarkers could be useful in monitoring the disease and efficacy of treatment.

KW - Systemic sclerosis

KW - collagen

KW - metabolites

KW - modified Rodnan skin score

KW - scleroderma

U2 - 10.1080/1354750X.2019.1587509

DO - 10.1080/1354750X.2019.1587509

M3 - Journal article

C2 - 30821519

VL - 24

SP - 373

EP - 378

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 4

ER -

ID: 228780064